Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
about
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.Healthcare professionals' views of the use and administration of two salvage therapy drugs for acute ulcerative colitis: a nested qualitative study within the CONSTRUCT trial.New treatment strategies for ulcerative colitis.Optimizing pharmacologic management of inflammatory bowel disease.Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.Acute severe ulcerative colitis: from pathophysiology to clinical management.Infliximab or ciclosporin for acute severe ulcerative colitis?A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply.Letter: dose optimising infliximab in acute severe ulcerative colitis.Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.Estimation of Quality-adjusted Life Years alongside clinical trials: the impact of 'time-effects' on trial results.
P2860
Q31140142-64F5BC79-9BFC-459A-9F68-5CF8FD5C30A0Q37681244-985FC436-11BD-4931-9A43-B88F4BF66739Q38670811-A789E5F8-641F-45DC-A264-0533817474E6Q38687407-A3E99A44-7264-4C8E-9AE1-8E737F805984Q38724227-2F3844D9-DFC1-413C-A7F6-81E2D78EBFEAQ38942561-6497B100-1689-40E2-89AC-68BC51BA8C12Q42381018-A0BC6FA2-36C2-4B3C-B2F2-2C4AA7721F6DQ45835949-187AF7B6-95AB-4830-8EC7-FF8C0AB4D550Q45990517-A234668F-E810-44EA-A93E-F9C896B703F7Q48094924-D851B349-3D22-4017-8019-4E6E8ACD36DBQ48094974-C6FCE3EE-F325-41D3-B03C-0F1570602DA3Q50097248-3CD84F72-1676-4CA4-8CE4-F5757141E304Q55270260-622E2F2E-DA5D-477D-A62C-92CA06C1F607
P2860
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infliximab versus ciclosporin ...... el, pragmatic randomised trial
@en
Infliximab versus ciclosporin ...... l, pragmatic randomised trial.
@nl
type
label
Infliximab versus ciclosporin ...... el, pragmatic randomised trial
@en
Infliximab versus ciclosporin ...... l, pragmatic randomised trial.
@nl
prefLabel
Infliximab versus ciclosporin ...... el, pragmatic randomised trial
@en
Infliximab versus ciclosporin ...... l, pragmatic randomised trial.
@nl
P2093
P2860
P50
P1476
Infliximab versus ciclosporin ...... el, pragmatic randomised trial
@en
P2093
A Barney Hawthorne
Aida U Jawhari
Anne C Seagrove
David Cohen
Ian Arnott
Jayne M Morgan
John G Williams
John Mansfield
John N Gordon
P2860
P356
10.1016/S2468-1253(16)30003-6
P577
2016-09-01T00:00:00Z